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It is often noted that fashion goes in cycles; keep those 
old clothes in the wardrobe long enough and they will 
enjoy a renaissance eventually! It seems that this is also 
true of many great ideas in science. In a previous issue, 
Bussard and colleagues [1] reacquaint us with John 
Cairns’ immortal strand hypothesis, postulated some 35 
years ago [2]. Cairns’ hypothesis still remains relatively 
unknown to the majority of cancer researchers, perhaps 
in part due to the more esoteric nature of his proposal, 
and the diﬃ   culty of proving it.
Cairns published his hypothesis around the time that 
Knudson was popularizing Nordling’s [3] concepts of 
multiple mutations being required for the genesis of 
cancer, through his own careful analysis of inherited 
retino  blastoma [4]. Th  e notion of natural selection of 
cells carrying mutations that give a favourable survival 
advantage is now well established in cancer biology. 
However, Cairns recognized a problem with this concept: 
given the very large number of cell divisions in tissues 
like the skin, gut and bone marrow, he thought it 
surprising that there should be as little cancer as there is, 
if mutations arise at the rate that was estimated to be the 
case. Why was this so?
Cairns focused his attention on the concept of adult 
stem cells that were understood to be responsible for the 
replenishment of rapidly dividing tissues, and to reside 
within cellular hierarchies in various tissues, such as the 
haematopoietic system. It was hypothesized that stem 
cells undergo asymmetric division, giving rise to two 
progeny: one destined to remain as an undiﬀ  erentiated 
stem cell (self renewal) and one that could go on and 
divide again to give rise to progeny that expand in 
number and undergo diﬀ   erentiation. Various mecha-
nisms whereby asymmetric division may occur have been 
elaborated in a recent review by Knoblich [5].
Th  e concept of a cancer stem cell is also enjoying a 
resurgence, having essentially been proposed by Julius 
Cohnheim in 1867 [6] when he postulated that malig-
nancies arise from ‘embryonic rests’. Cairns reasoned that 
there may be less cancer than might be expected because 
stem cells divide less frequently and are fewer in number, 
but he went further by making the radical proposal that 
they also protect one of their DNA strands during semi-
conservative replication. Th  at is, once a stem cell is 
formed, one of its DNA strands remains selectively 
segregated into a stem cell during division (as part of self 
renewal of that cell), reducing the likelihood of mutations 
accumulating in the stem cells during subsequent DNA 
replication.
Th  is is not an easy concept and to some extent it is 
open to accusations of teleology. What Cairns needed 
was an experimental model, and he was ably helped in 
this regard by Chris Potten. Th  eir initial DNA labelling 
experiment [7] provided experimental evidence for the 
hypothesis and has since inspired a great deal of research 
in this area. Th   ey demonstrated that intestinal epithelial 
cells in the mouse could be labelled with markers of DNA 
synthesis (such as tritiated thymidine, 3H-TdR, or 
5-bromodeoxyuridine, BrdU), and that cells retaining 
this label could be found in zones where stem cells were 
postulated to reside. More recently they have 
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manner that they retain an initial label (3H-TdR) and may 
also take up another (BrdU) that is subsequently lost, 
proving that self renewing cells selectively segregate their 
tem  plate strands [8]. Th   is work is the inspiration behind 
the work of Bussard and colleagues here, in their 
mammary epithelial model.
In many ways, the mouse mammary gland is an ideal 
model for experimentation aimed at elucidating how 
stem cells function in vivo. Ken DeOme and colleagues 
[9] showed that the cleared mammary fat pad could be 
used as an in vivo ‘growth chamber’ and that small por-
tions of mammary epithelium could regrow into func-
tion  ing mammary glands when transplanted into the fad 
pad. Th   is model has been used by numerous groups since 
and, incredibly, Shackleton and colleagues [10] have 
shown that a single cell (deﬁ  ned as Lin-CD29hiCD24+) can 
give rise to an entire functioning mammary gland.
In this paper, Bussard and her colleagues used an 
immortalized premalignant mammary epithelial cell line, 
COMMA-D1, to derive subpopulations with diﬀ  erent 
properties. Using these cells transplanted in the mammary 
fat pad model, they demonstrate that there exist subsets 
of long-lived label-retaining epithelial cells (LRECs) that 
can divide asymmetrically and retain their labelled 
strand. Th   eir progeny can diﬀ  erentiate to form ductal or 
lobular structures and expand and diﬀ  erentiate in res-
ponse to pregnancy. Th   ese cells may also take up a new 
label (BrdU) that is lost with subsequent divisions, just as 
Potten and colleagues [8] observed in intestinal cells.
Th  ese  ﬁ   ndings lend further support for Cairns’ 
hypothesis, but more signiﬁ  cantly by their use of a pre-
malignant cell line emphasise the importance of the 
cancer stem cell concept. Th   e clinical implications of this 
hypothesis have been well recognized: many current 
cytotoxic therapies (including radiotherapy and many 
conventional chemotherapeutic agents, such as spindle 
poisons) are based on killing rapidly dividing cells. Th  at 
we may be targeting the wrong population, or not 
measur  ing our success appropriately, has been well 
reviewed [11,12]. Bussard and colleagues provide a timely 
reminder that we are still some way oﬀ   targeting cancer 
stem cells, even some 35 years after Cairns published his 
revolutionary idea. Th   at we are getting closer to 
understanding the nature of these stem cells provides 
hope that strategies aimed at identifying them in human 
cancer, and targeting them, are a step closer to reality.
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